2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$9.73-$0.11 (-1.10%)
Price as of Aug 21, 2026 7:57 PM EDT- $2.2BMarket Cap
- -44.72%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$9.73-$0.11 (-1.10%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.84 | ||
Change | +$0.08 (+0.82%) | ||
Open | $9.77 | ||
High | $9.95 | ||
Low | $9.68 | ||
Previous Close | $9.76 | ||
Volume | 1,477,002 | ||
30-Day Average Volume | 2,379,444 | ||
1-Week Change | 3.91% | ||
1-Month Change | 14.55% | ||
1-Year Change | -44.72% | ||
3-Year Change | 143.56% | ||
5-Year Change | 706.56% | ||
Fundamentals | |||
Shares Outstanding | 224.0M | ||
Total Assets | $684.2M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $124.4M | ||
Net Income | $37.8M | ||
Free Cash Flow | $27.3M | ||
EBIT | $50.2M | ||
EBITDA | $52.0M | ||
Net Working Capital | $452.4M | ||
EPS | $0.16 | ||
Enterprise Value/EBITDA | 44 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 5 | ||
P/E | 62 | ||
PEG | -4 | ||
Price/Free Cash Flow | 81 | ||
Price/Operating Cash Flow | 75 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue